Meilleure Health International Industry Group Limited announced that its share capital structure remained unchanged for the month ended 31 July 2026.

Authorised and Issued Capital • Authorised share capital held steady at 10.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 100.00 million. • Issued shares (excluding treasury) were unchanged at 4.06 billion. Treasury shares stood at 5.33 million, keeping total issued shares at 4.06 billion. Consequently, 40.6% of the group’s authorised share limit has been utilised, leaving significant headroom for future issuance.

Public Float Compliance • The company affirmed compliance with the Main Board’s minimum 25% public-float requirement as of 31 July 2026. Treasury shares represent only 0.13% of total issued shares, exerting minimal impact on liquidity calculations.

Equity Incentive Instruments • 2019 Share Option Scheme: 16.97 million options remained outstanding, equal to roughly 0.42% of the current issued share base. No options were granted, exercised, cancelled or lapsed during July. The scheme still allows up to 427.18 million additional shares (10.53% of issued share capital) to be granted in future. • 2026 Share Award Scheme: No shares were issued or transferred in July. Up to 408.84 million shares (10.07% of issued share capital) are available for future awards.

Capital Movements • The company reported zero changes in issued shares and zero movements in treasury shares during the month. • No warrants, convertible securities or other share-issuance arrangements were outstanding or exercised.

Takeaways Meilleure Health maintained a stable capital structure in July 2026, with no dilution events and sufficient public float. Existing option and share-award reserves, if fully exercised or granted, could expand the share base by up to 20.6%, but no activity occurred during the period reported.